Peer Review reports
From: HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3
| Original Submission | ||
|---|---|---|
| 18 Jun 2021 | Submitted | Original manuscript |
| 29 Jul 2021 | Reviewed | Reviewer Report |
| 31 Jul 2021 | Reviewed | Reviewer Report |
| 9 Nov 2021 | Author responded | Author comments - Jianrui Sun |
| Resubmission - Version 2 | ||
| 9 Nov 2021 | Submitted | Manuscript version 2 |
| 17 Nov 2021 | Author responded | Author comments - Jianrui Sun |
| Resubmission - Version 3 | ||
| 17 Nov 2021 | Submitted | Manuscript version 3 |
| 2 Dec 2021 | Author responded | Author comments - Jianrui Sun |
| Resubmission - Version 4 | ||
| 2 Dec 2021 | Submitted | Manuscript version 4 |
| 16 Dec 2021 | Author responded | Author comments - Jianrui Sun |
| Resubmission - Version 5 | ||
| 16 Dec 2021 | Submitted | Manuscript version 5 |
| 14 Jan 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 7 Feb 2022 | Editorially accepted | |
| 6 Apr 2022 | Article published | 10.1186/s12885-022-09462-y |
You can find further information about peer review here.